Développement d’une approche théragnostique du cancer de l’ovaire à l’aide d’anticorps anti-AMHR2 radiomarqués

Développement d’une approche théragnostique du cancer de l’ovaire à l’aide d’anticorps anti-AMHR2 radiomarqués

Le cancer de l’ovaire est la première cause de décès par cancer gynécologique en France et il présente un fort taux de récidive justifiant la recherche de nouvelles thérapeutiques. Notre projet consiste à développer et à explorer sur des modèles expérimentaux précliniques de carcinose péritonéale de...

Full description

Bibliographic Details
Main Author:	Deshayes, Emmanuel
Other Authors:	Montpellier
Language:	fr
Published:	2018
Subjects:	Radioimmunothérapie Radiobiologie Carcinose péritonéale Cancer de l'ovaire Dosimétrie Théragnostic Anticorps monoclonaux Émetteurs de particule alpha Émetteurs de particule beta AMHR2 MISRII Radioimmunotherapy Radiobiology Peritoneal carcinomatosis Ovarian cancer Dosimétry Theranostic Monoclonal antibodies Alpha particle emitters Beta particle emitters MISR2
Online Access:	http://www.theses.fr/2018MONTT078

Similar Items

Contribution des effets ciblés et non ciblés en radioimmunothérapie alpha et Auger de carcinoses péritonéales
by: Ladjohounlou, Riad
Published: (2016)

Can polymorphisms of AMH/AMHR2 affect ovarian stimulation outcomes? A systematic review and meta-analysis
by: Di Chen, et al.
Published: (2020-09-01)

The Relationship between AMH and AMHR2 Polymorphisms and the Follicular Phase in Late Reproductive Stage Women
by: Anna Jurczak, et al.
Published: (2016-02-01)

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
by: Ashleigh Hull, et al.
Published: (2020-02-01)

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model
by: Jessie R. Nedrow, et al.
Published: (2017-07-01)

AMH and AMHR2 Polymorphisms and AMH Serum Level Can Predict Assisted Reproduction Outcomes: A Cross-Sectional Study
by: Carla Peluso, et al.
Published: (2015-03-01)

Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
by: Nastassja Terraneo, et al.
Published: (2020-03-01)

Contribution à l'étude du couplage thermo-mécanique entre un émetteur de chauffage et son environnement
by: Hemmer, Cédric
Published: (2015)

Human dosimetry of free 211At and meta-[211At]astatobenzylguanidine (211At-MABG) estimated using preclinical biodistribution from normal mice
by: Naoyuki Ukon, et al.
Published: (2020-09-01)

Etude d'un nouvel anticorps anti-CD37 radiomarqué au Lutétium-177 dans le traitement du lymphome B non hodgkinien : efficacité thérapeutique et mécanismes d'action
by: Pichard, Alexandre
Published: (2017)

The potential and hurdles of Targeted Alpha Therapy - Clinical trials and beyond
by: Jorgen eElgqvist, et al.
Published: (2014-01-01)

Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
by: George Sgouros, et al.
Published: (2021-08-01)

Tumor Immunotargeting Using Innovative Radionuclides
by: Françoise Kraeber-Bodéré, et al.
Published: (2015-02-01)

Therapeutic efficacy of alpha-RIT using a 213Bi-anti-hCD138 antibody in a mouse model of ovarian peritoneal carcinomatosis
by: Aurélie eDerrien, et al.
Published: (2015-12-01)

Radiation dosimetry of radioimmunotherapy antibodies conjugated with ��Y
by: Al-Hussan, Khalid A.I. Eleissa
Published: (2012)

Conception sur silicium de convertisseurs analogique-numérique haut débit pour le radiotélescope SKA
by: Da Silva, Bruno
Published: (2010)

Pharmacokinetics and Dosimetry Studies for Optimization of Pretargeted Radioimmunotherapy in CEA-Expressing Advanced Lung Cancer Patients
by: Caroline eBodet-Milin, et al.
Published: (2015-11-01)

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy
by: Weronika Gawęda, et al.
Published: (2020-10-01)

Subcellular Targeting of Theranostic Radionuclides
by: Bas M. Bavelaar, et al.
Published: (2018-09-01)

Nouvelles modalités (consolidation, fractionnement) de radioimmunothérapie par 90Y-ibritumomab tiuxetan ("Zevalin") en traitement de première ligne des lymphomes malin non hodgkinien de type folliculaire: efficacité, toxicité et approche dosimétrique personnalisée
by: Morschhauser, Franck
Published: (2008)

Contamination des composants électroniques par des éléments radioactifs
by: Gedion, Michael
Published: (2012)

Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors
by: Tom A. Bäck, et al.
Published: (2020-02-01)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
by: Andrea Cimini, et al.
Published: (2020-05-01)

Persistent Mullerian duct Syndrome in a Brazilian miniature schnauzer dog
by: DENISE M. NOGUEIRA, et al.

Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
by: Anna Gustafsson-Lutz, et al.
Published: (2017-04-01)

Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (<sup>111</sup>In)/Yttrium 90 (<sup>90</sup>Y) Ibritumomab Tiuxetan (Zevalin<sup>®</sup>) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
by: Richard L. Wahl, et al.
Published: (2021-06-01)

Études Structurales et Photophysiques de Polymères de Coordination de Thiolates de Métaux Monétaires
by: Veselska, Oleksandra
Published: (2019)

Embryo quality predictive models based on cumulus cells gene expression
by: Devjak R, et al.
Published: (2016-06-01)

Desenvolvimento de um sistema dosimetrico para monitoracao individual em campo misto beta e gama
by: DALTRO, TERESINHA F.L.
Published: (1996)

Desenvolvimento de um sistema dosimetrico para monitoracao individual em campo misto beta e gama
by: DALTRO, TERESINHA F.L.
Published: (1996)

AMH Concentrations in Peritoneal Fluids of Women With and Without Endometriosis
by: Michio Kitajima, et al.
Published: (2020-11-01)

Dosimetry of <sup>177</sup>Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol
by: Anna Sarnelli, et al.
Published: (2019-02-01)

Recherche de galaxies avec un grand décalage spectral vers le rouge (z=7.7) par imagerie en bande étroite
by: Clement, Benjamin
Published: (2011)

Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial
by: Diane E. Milenic, et al.
Published: (2015-07-01)

A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
by: Robin M. de Kruijff, et al.
Published: (2015-06-01)

Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)
by: Maria Luisa Belli, et al.
Published: (2020-11-01)

The Radiochemical and Radiopharmaceutical Applications of Radium
by: Gott Matthew, et al.
Published: (2016-01-01)

The feasibility and toxicity of direct intratumoral injections of yttrium-90 ('9'0Y) radioimmunoconjugates in the treatment of patients with malignant gliomas
by: Hopkins, K.
Published: (1996)

Pre-Clinical Assessment of 177Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
by: Diane E. Milenic, et al.
Published: (2011-12-01)

Safety Evaluation of an Alpha-Emitter Bismuth-213 Labeled Antibody to (1→3)-β-Glucan in Healthy Dogs as a Prelude for a Trial in Companion Dogs with Invasive Fungal Infections
by: Muath Helal, et al.
Published: (2020-08-01)